In DLBCL, focal deletions of the PVT1 promoter was suggested to promote MYC overexpression and a double-hit-like expression pattern in germinal center type tumors lacking MYC and/or BCL2 rearrangements [63]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.